BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32152220)

  • 1. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
    Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma suppression by quercein is correlated with RIG-I and type I interferon signaling.
    Peng D; Chen L; Sun Y; Sun L; Yin Q; Deng S; Niu L; Lou F; Wang Z; Xu Z; Wang C; Fan L; Wang H; Wang H
    Biomed Pharmacother; 2020 May; 125():109984. PubMed ID: 32066042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
    Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
    Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIG-I enhances interferon-α response by promoting antiviral protein expression in patients with chronic hepatitis B.
    Wu S; Lin J; Fu Y; Ou Q
    Antivir Ther; 2018; 23(7):575-583. PubMed ID: 29790851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.
    Kong LY; Gelbard A; Wei J; Reina-Ortiz C; Wang Y; Yang EC; Hailemichael Y; Fokt I; Jayakumar A; Qiao W; Fuller GN; Overwijk WW; Priebe W; Heimberger AB
    Clin Cancer Res; 2010 May; 16(9):2550-61. PubMed ID: 20388845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy.
    Jia Q; Yang F; Huang W; Zhang Y; Bao B; Li K; Wei F; Zhang C; Jia H
    Theranostics; 2019; 9(2):424-435. PubMed ID: 30809284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line.
    Badgwell B; Lesinski GB; Magro C; Abood G; Skaf A; Carson W
    J Surg Res; 2004 Jan; 116(1):129-36. PubMed ID: 14732359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.
    Hergovits S; Mais C; Haan C; Costa-Pereira AP; Hermanns HM
    J Cell Mol Med; 2017 Nov; 21(11):3087-3099. PubMed ID: 28560754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects.
    Brown L; Roda J; Terrell C; Chaudhury AR; Crespin T; Carson WE; Lesinski GB
    Surgery; 2006 Aug; 140(2):297-306. PubMed ID: 16904983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.
    Critchley-Thorne RJ; Yan N; Nacu S; Weber J; Holmes SP; Lee PP
    PLoS Med; 2007 May; 4(5):e176. PubMed ID: 17488182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 pretreatments enhance IFN-alpha-induced Janus kinase-STAT signaling and potentiate the antitumor effects of IFN-alpha in a murine model of malignant melanoma.
    Lesinski GB; Badgwell B; Zimmerer J; Crespin T; Hu Y; Abood G; Carson WE
    J Immunol; 2004 Jun; 172(12):7368-76. PubMed ID: 15187113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways.
    Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J
    Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation.
    Bai Y; Ahmad U; Wang Y; Li JH; Choy JC; Kim RW; Kirkiles-Smith N; Maher SE; Karras JG; Bennett CF; Bothwell AL; Pober JS; Tellides G
    J Biol Chem; 2008 Mar; 283(11):6832-42. PubMed ID: 18192275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
    Fang P; Hwa V; Rosenfeld RG
    Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.
    Besch R; Poeck H; Hohenauer T; Senft D; Häcker G; Berking C; Hornung V; Endres S; Ruzicka T; Rothenfusser S; Hartmann G
    J Clin Invest; 2009 Aug; 119(8):2399-411. PubMed ID: 19620789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3/p53 pathway activation disrupts IFN-β-induced dormancy in tumor-repopulating cells.
    Liu Y; Lv J; Liu J; Liang X; Jin X; Xie J; Zhang L; Chen D; Fiskesund R; Tang K; Ma J; Zhang H; Dong W; Mo S; Zhang T; Cheng F; Zhou Y; Jia Q; Zhu B; Kong Y; Guo J; Zhang H; Hu ZW; Cao X; Qin FX; Huang B
    J Clin Invest; 2018 Mar; 128(3):1057-1073. PubMed ID: 29431732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
    Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
    Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Src-family-tyrosine kinase, Lyn, is required for efficient IFN-β expression in pattern recognition receptor, RIG-I, signal pathway by interacting with IPS-1.
    Lim YJ; Koo JE; Hong EH; Park ZY; Lim KM; Bae ON; Lee JY
    Cytokine; 2015 Mar; 72(1):63-70. PubMed ID: 25585356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS).
    Tong S; Cinelli MA; El-Sayed NS; Huang H; Patel A; Silverman RB; Yang S
    Sci Rep; 2022 Feb; 12(1):1701. PubMed ID: 35105915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.